Berthold A Nock

28PUBLICATIONS
31CO-AUTHORS
Autonomic nervous systemPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 27, 2026
Neurotensin-Based Radioligands for NTS1R-Targeted Cancer Theranostics: Background, Current Status and Future Trends.

|Oct 29, 2025
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Anna Orlova, Anastasia Rybina, Anna Medvedeva

|Aug 28, 2025
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8.

Olga Bragina, Vladimir Chernov, Mariia Larkina

|Mar 27, 2025
Reshaping [99mTc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTS1R-Positive Cancer Theranostics.

Panagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning

|Sep 28, 2024
Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results.

Maria Bibika, Panagiotis Kanellopoulos, Maritina Rouchota

|Apr 27, 2024
GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics.

Karim Obeid, Panagiotis Kanellopoulos, Ayman Abouzayed

Pageof 5

Frequent Collaborators

27 joint publications

Theodosia Maina

13 joint publications

Panagiotis Kanellopoulos

4 joint publications

Anna Orlova

4 joint publications

Vladimir Tolmachev